Attention deficit hyperactivity disorder (ADHD) is characterized by hyperactivity, inattention, and impulsivity. The coloboma mouse model of ADHD exhibits profound hyperactivity. To determine whether coloboma mice exhibit other signs of ADHD, we assessed latent inhibition as a test of attention, and impulsivity in a delayed reinforcement paradigm. Latent inhibition was present in control mice but was disrupted in coloboma mice. Coloboma mice also exhibited impaired performance on the delayed reinforcement task and were not able to wait as long as control mice to obtain the greater reinforcer. Because norepinephrine mediates hyperactivity in coloboma mice, we examined the role of norepinephrine in disrupted latent inhibition and impulsivity. Reduction of norepinephrine with DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride) restored latent inhibition but did not ameliorate impulsivity. In summary, coloboma mice exhibit hyperactivity, inattention as determined by latent inhibition, and impulsivity, and norepinephrine mediates hyperactivity and inattention but not impulsivity in these mice.
Introduction
Attention deficit hyperactivity disorder (ADHD) is characterized by hyperactivity, inattention, and impulsivity. Although ADHD is a common pediatric neuropsychiatric disorder (Olfson, 1992; Faraone et al., 2003) , the etiology is unknown. It is almost certain that multiple factors, both genetic and environmental, contribute to the expression of ADHD (Biederman, 2005; Biederman et al., 2002; Faraone et al., 2005; Hudziak et al., 2005) . Consequently, ADHD is a heterogeneous disorder with variability in both behavioral expression and drug responses observed among patients, as documented in DSM-IV (Frances et al., 1994) . The complexity and heterogeneity of the disorder make ADHD difficult to study in humans. Therefore, animal models are useful for understanding the mechanisms underlying ADHD and for developing new pharmacological therapies.
There are several animal models that bear a phenotypic, pathophysiological, or etiological resemblance to ADHD and, therefore, are considered valid models of ADHD. Face validity, the phenotypic reproduction of the disorder, is observed in all current models of ADHD. All models, including juvenile rats with neonatal 6-hydroxydopamine lesions, dopamine transporter (DAT) knockout or knockdown mice and Naples high-excitability rats, exhibit hyperactivity (Shaywitz et al., 1976b; Sadile et al., 1993; Luthman et al., 1997; Gainetdinov et al., 1999; Zhuang et al., 2001) . Others, including spontaneously hypertensive rats, exhibit all 3 core symptoms of ADHD-hyperactivity, inattention, and impulsivity (Sagvolden, 2000; Sagvolden et al., 2005) . Construct validity, the resemblance of pathophysiology or pharmacological response to the human disorder, is also observed in most animal models of ADHD. For example, just as psychostimulants ameliorate the symptoms of ADHD in humans, they also reduce the hyperactivity observed in rats treated neonatally with 6-hydroxydopamine, spontaneously hypertensive rats, and DAT knockout mice (Shaywitz et al., 1976a; Heffner and Seiden, 1982; Myers et al., 1982; Luthman et al., 1989; Sagvolden et al., 1992; Gainetdinov et al., 1999; Davids et al., 2002) . Because ADHD is a multigenic disorder with no single gene identified as a major risk factor, etiological validity is difficult to establish in models of ADHD. However, the DAT mutant models may have etiological validity inasmuch as a recent meta-analysis of genetic association studies in humans suggests that a polymorphism in the gene encoding DAT is a modest risk factor in ADHD (Faraone et al., 2005) .
